XYLO-POS Israel - English - Ministry of Health

xylo-pos

kivema ltd - xylometazoline hydrochloride - spray - xylometazoline hydrochloride 1 mg/ml - xylometazoline - xylometazoline - rapid relief of nasal congestion for up to ten hours.

Emdocam European Union - English - EMA (European Medicines Agency)

emdocam

emdoka bvba - meloxicam - oxicams - horses; pigs; cattle - cattlefor use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs. for use in diarrhoea in combination with oral rehydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle. for adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy.pigsfor use in noninfectious locomotor disorders to reduce the symptoms of lameness and inflammation. for adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitits-metritis-agalactia syndrome) with appropriate antibiotic therapy.horsesfor use in the alleviation of inflammation and relief of pain in both acute and chronic musculoskeletal disorders. for the relief of pain associated with equine colic.dogs: alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders. reduction of post-operative pain and inflammation following orthopaedic and soft tissue surgery.cats:reduction of post-operative pain after ovariohysterectomy and minor soft tissue surgery.

Halagon European Union - English - EMA (European Medicines Agency)

halagon

emdoka bvba - halofuginone lactate - halofuginone, other antiprotozoal agents - calves, newborn - in newborn calves:prevention of diarrhoea due to diagnosed cryptosporidium parvum infection, in farms with history of cryptosporidiosis. administration should start in the first 24 to 48 hours of age.reduction of diarrhoea due to diagnosed cryptosporidium parvum infection. administration should start within 24 hours after the onset of diarrhoea. in both cases, the reduction of oocysts excretion has been demonstrated.

Siofor SR 1000 mg prolonged-release tablets Ireland - English - HPRA (Health Products Regulatory Authority)

siofor sr 1000 mg prolonged-release tablets

a. menarini pharmaceuticals ireland ltd - metformin hydrochloride ph. eur. - prolonged-release tablet - 1000 milligram(s) - biguanides; metformin

Siofor SR 500 mg prolonged-release tablets Ireland - English - HPRA (Health Products Regulatory Authority)

siofor sr 500 mg prolonged-release tablets

a. menarini pharmaceuticals ireland ltd - metformin hydrochloride ph. eur. - prolonged-release tablet - 500 milligram(s) - biguanides; metformin

Siofor SR 750 mg prolonged-release tablets Ireland - English - HPRA (Health Products Regulatory Authority)

siofor sr 750 mg prolonged-release tablets

a. menarini pharmaceuticals ireland ltd - metformin hydrochloride ph. eur. - prolonged-release tablet - 750 milligram(s) - biguanides; metformin

Fampyra European Union - English - EMA (European Medicines Agency)

fampyra

biogen netherlands b.v.  - fampridine - multiple sclerosis - other nervous system drugs - fampyra is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (expanded disability status scale 4-7).

Tecfidera European Union - English - EMA (European Medicines Agency)

tecfidera

biogen netherlands b.v. - dimethyl fumarate - multiple sclerosis - immunosuppressants - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Plegridy European Union - English - EMA (European Medicines Agency)

plegridy

biogen netherlands b.v. - peginterferon beta-1a - multiple sclerosis - immunostimulants, - treatment of relapsing remitting multiple sclerosis in adult patients.